Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Clinical trial NCT04383210 · TERMINATED
Trial details
- NCT number
- NCT04383210
- Sponsor
- Elevation Oncology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2024-02-28
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.